Study of LC-OCT skin imaging in daily practice
Part of Cancer clinical trials.
This study looks at how well a new skin imaging tool (LC-OCT) works in everyday care for people being treated for skin cancer at Mohs clinics in the Netherlands. If you had this test and have follow-up information, your data could help doctors understand how useful the test really is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You had a special skin imaging test called LC-OCT between January and June 2025 at a Mohs surgery clinic in the Netherlands.
- You have either results from a biopsy or surgery, or follow-up visit notes from 6 to 12 months later.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses an advanced AI-assisted imaging device to see the edges of a common skin cancer called basal cell carcinoma before surgery. It may help doctors remove the cancer more precisely, possibly reducing the need for repeat procedures.
This trial uses a special microscope to look at skin biopsy samples in new ways. It may help doctors understand skin conditions better without needing extra procedures.
This study uses information from a European registry to learn how real-world treatments work for advanced non-melanoma skin cancers. It may help doctors improve care in the future, especially for people who have had surgery and radiation or who cannot have curative treatments.
This trial tests a personalized aftercare report for people with low-risk skin cancer. It aims to see if this report can improve follow-up care.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
This study tests a new imaging tool called LC-OCT to see if it helps doctors remove all skin cancer during Mohs surgery. It might reduce the need for extra surgeries by giving clearer pictures in real time.
Hear when a new Basal Cell Carcinoma of Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.